Sex differences in COMT polymorphism effects on prefrontal inhibitory control in adolescence

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • King's College London (KCL)
  • Medical Research Council (MRC)
  • Vrije Universiteit Amsterdam (VU)
  • University of Vermont
  • Universität Heidelberg
  • Trinity College Dublin
  • Universität Hamburg
  • University of Montreal
  • Commissariat à l’énergie atomique et aux énergies alternatives (CEA)
  • Charité – Universitätsmedizin Berlin
  • University of Nottingham
  • Physikalisch-Technische Bundesanstalt
  • INSERM - Institut national de la santé et de la recherche médicale
  • Université Paris Cité
  • University of Toronto
  • Centre Universitaire de Sante McGill
  • University of Cambridge

Abstract

Catecholamine-0-methyl-transferase (COMT) gene variation effects on prefrontal blood oxygenation-level-dependent (BOLD) activation are robust; however, despite observations that COMT is estrogenically catabolized, sex differences in its prefrontal repercussions remain unclear. Here, in a large sample of healthy adolescents stratified by sex and Val 158 Met genotype (n=1133), we examine BOLD responses during performance of the stop-signal task in right-hemispheric prefrontal regions fundamental to inhibitory control. A significant sex-by-genotype interaction was observed in pre-SMA during successful-inhibition trials and in both pre-SMA and inferior frontal cortex during failed-inhibition trials with Val homozygotes displaying elevated activation compared with other genotypes in males but not in females. BOLD activation in the same regions significantly mediated the relationship between COMT genotype and inhibitory proficiency as indexed by stop-signal reaction time in males alone. These sexually dimorphic effects of COMT on inhibitory brain activation have important implications for our understanding of the contrasting patterns of prefrontally governed psychopathology observed in males and females.

Details

OriginalspracheEnglisch
Seiten (von - bis)2560-2569
Seitenumfang10
FachzeitschriftNeuropsychopharmacology
Jahrgang39
Ausgabenummer11
PublikationsstatusVeröffentlicht - 1 Okt. 2014
Peer-Review-StatusJa

Externe IDs

PubMed 24820538
ORCID /0000-0001-5398-5569/work/161890820

Schlagworte

Bibliotheksschlagworte